Victor Cervera-Carrascon graduated as Master of Pharmacy at
Complutense University of Madrid (Spain) in February 2016
following the defense of his Master thesis related to oncolytic
viruses and their role in the reversion of tumor immune tolerance.
The same February, Victor joined TILT Biotherapeutics Ltd team as
PhD student included in the VIRION network.